Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yves Sonigo"'
Publikováno v:
Néphrologie & Thérapeutique. 9:486-493
Resume L’anemie est un symptome frequent chez les patients atteints de maladie renale chronique (MRC), debutant un traitement par hemodialyse (HD), corrige par un apport approprie de fer et d’agent stimulant l’erythropoiese (ASE). L’objectif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abe420de31d58aef719566de284e1359
https://doi.org/10.1016/j.nephro.2013.07.364
https://doi.org/10.1016/j.nephro.2013.07.364
Publikováno v:
Journal of Clinical Case Reports. 4
Background: An unacceptably high number of patients start dialysis with pronounced anaemia. The aim of this retrospective study was to provide insights into the impact of the pre-dialysis correction of anaemia (using an ESA) and iron deficiency (usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c34f9a9d4df0e36f9060b53bf5cc2a3
https://doi.org/10.4172/2165-7920.1000462
https://doi.org/10.4172/2165-7920.1000462
Publikováno v:
Nephrologietherapeutique. 9(7)
Individualized use of iron therapy (IT) and erythropoiesis-stimulating agents (ESA) may effectively correct anemia and its symptoms in CKD patients (Pts). The aim of this retrospective study was to precise the anemia management (AM) in incident HD Pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05d98e12e7c507307181187739424d68
https://pubmed.ncbi.nlm.nih.gov/24113201
https://pubmed.ncbi.nlm.nih.gov/24113201